First-line systemic treatment strategies for unresectable hepatocellular carcinoma: a cost-effectiveness analysis

wang, L., Peng, Y., Qin, S. et al. (5 more authors) (2023) First-line systemic treatment strategies for unresectable hepatocellular carcinoma: a cost-effectiveness analysis. PLOS ONE, 18 (4). e0279786. ISSN 1932-6203

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2023 wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/).
Keywords: Hepatocellular carcinoma; Drug therapy; Cancer treatment; Drug prices; Chinese people; Health economics; Markov models
Dates:
  • Accepted: 17 March 2023
  • Published (online): 13 April 2023
  • Published: 13 April 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Social Sciences (Sheffield) > Department of Geography (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 20 Apr 2023 11:18
Last Modified: 20 Apr 2023 11:18
Published Version: http://dx.doi.org/10.1371/journal.pone.0279786
Status: Published
Publisher: Public Library of Science (PLoS)
Refereed: Yes
Identification Number: https://doi.org/10.1371/journal.pone.0279786
Related URLs:

Export

Statistics